期刊
JAMA NEUROLOGY
卷 71, 期 4, 页码 490-494出版社
AMER MEDICAL ASSOC
DOI: 10.1001/jamaneurol.2013.4677
关键词
-
资金
- Research Committee of Central Nervous System Degenerative Diseases from the Japanese Ministry of Health, Labor, and Welfare
- National Institutes of Health [NS081282, DA021743, DA026405]
IMPORTANCE Mutations in the GNAL. gene have recently been shown to cause primary torsion dystonia. The GNAL -encoded protein (Ga-olf) is important for dopamine D, receptor function and odorant signal transduction. We sequenced all 12 exons of GNAL in 461 patients from Germany, Serbia, and Japan, including 318 patients with dystopia (190 with cervical dystonia), 51 with hyposmia and Parkinson disease, and 92 with tardive dyskinesia or acute dystonic reactions. OBSERVATIONS We identified the following two novel heterozygous putative mutations in GNAL: p.Gly213Ser in a German patient and p.Ala353Thr in a Japanese patient. These variants were predicted to be pathogenic in silico, were absent in ethnically matched control individuals, and impaired Ga-olf coupling to D-1 receptors in a bioluminescence energy transfer (BRET) assay. Two additional variants appeared to be benign because they behaved like wild-type samples in the BRET assay (p.Ala311Thr) or were detected in ethnically matched controls (p.Thr92Ala). Both patients with likely pathogenic mutations had craniocervical dystonia with onset in the fifth decade of life. No pathogenic mutations were detected in the patients with hyposmia and Parkinson disease, tardive dyskinesias, or acute dystonic reactions. CONCLUSIONS AND RELEVANCE Mutations in GNAL can cause craniocervical dystonia in different ethnicities. The BRET assay may be a useful tool to support the pathogenicity of identified variants in the GNAL gene.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据